Loading...
Researchers at Harvard and Oxford have developed an AI system that can predict new strains of COVID-19 and other viruses. The system, known as GenAI, is revolutionizing pharmaceutical research by aiding in the engineering of new medical antibodies and transforming the way drugs are computed. This breakthrough technology is set to have a significant impact on the development of treatments and vaccines for viral diseases, including the emergence of variants that may evade immune detection. The findings were published in a paper in Nature, highlighting the importance of this advancement in the scientific community.
Computing new drugs: GenAI is helping to transform pharmaceutical research https://t.co/ABzbD3yIE5
Researchers are taking a revolutionary, AI-powered approach to engineering new medical antibodies. https://t.co/Dg5A9aABeu
Researchers at Harvard and Oxford have created an #AI system that can predict new strains of COVID-19 and other viruses https://t.co/Q7CM6AWcbc
UiPath seeks to move GenAI beyond personal productivity https://t.co/5flezCJEYM
A new tool to predict viral evolution, in particular the emergence of variants that may be able to avoid immune detection, is described in a paper published in @Nature. https://t.co/3Er7nJMilL https://t.co/Jvz4J0Pucg